Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
금요일, 8월 28

Encompass Health Corp

EHCNYSE
Trade with Public
Trade with Public
$119.57
-1.21-1%
가까이에: Aug 26, 5:00 PM EST
$119.57
-1.21-1%
프리마켓: 8:22 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

Encompass Health Financials

Encompass Health (EHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs
Benzinga Newsdesk

PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the
Benzinga Newsdesk

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs
Benzinga Newsdesk

PRO
Encompass Health Q1 Adj. EPS $1.60 Beats $1.50 Estimate, Sales $1.586B Beat $1.569B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.50 by 6.67 percent. This is a 16.79 percent increase over earnings of $1.37 per share from the
Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

PRO
Encompass Health Sees FY2026 Adj EPS $5.81-$6.10 vs $5.81 Est; Sees Sales $6.365B-$6.465B vs $6.453B Est

Encompass Health (NYSE:EHC) is looking for FY2026 Adj EPS of $5.81-$6.10 vs $5.81 analyst estimate. sees sales of $6.365 billion-$6.465 billion vs $6.453 billion analyst estimate.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved